Serveur d'exploration sur la grippe en France

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Pandemic influenza due to pH1N1/2009 virus: estimation of infection burden in Reunion Island through a prospective serosurvey, austral winter 2009.

Identifieur interne : 000369 ( Main/Exploration ); précédent : 000368; suivant : 000370

Pandemic influenza due to pH1N1/2009 virus: estimation of infection burden in Reunion Island through a prospective serosurvey, austral winter 2009.

Auteurs : Koussay Dellagi [France] ; Olivier Rollot ; Sarah Temmam ; Nicolas Salez ; Vanina Guernier ; Hervé Pascalis ; Patrick Gérardin ; Adrian Fianu ; Nathanael Lapidus ; Nadège Naty ; Pablo Tortosa ; Karim Boussaïd ; Marie-Christine Jaffar-Banjee ; Laurent Filleul ; Antoine Flahault ; Fabrice Carrat ; Francois Favier ; Xavier De Lamballerie

Source :

RBID : pubmed:21980532

Descripteurs français

English descriptors

Abstract

BACKGROUND

To date, there is little information that reflects the true extent of spread of the pH1N1/2009v influenza pandemic at the community level as infection often results in mild or no clinical symptoms. This study aimed at assessing through a prospective study, the attack rate of pH1N1/2009 virus in Reunion Island and risk factors of infection, during the 2009 season.

METHODOLOGY/PRINCIPAL FINDINGS

A serosurvey was conducted during the 2009 austral winter, in the frame of a prospective population study. Pairs of sera were collected from 1687 individuals belonging to 772 households, during and after passage of the pandemic wave. Antibodies to pH1N1/2009v were titered using the hemagglutination inhibition assay (HIA) with titers ≥ 1/40 being considered positive. Seroprevalence during the first two weeks of detection of pH1N1/2009v in Reunion Island was 29.8% in people under 20 years of age, 35.6% in adults (20-59 years) and 73.3% in the elderly (≥ 60 years) (P<0.0001). Baseline corrected cumulative incidence rates, were 42.9%, 13.9% and 0% in these age groups respectively (P<0.0001). A significant decline in antibody titers occurred soon after the passage of the epidemic wave. Seroconversion rates to pH1N1/2009 correlated negatively with age: 63.2%, 39.4% and 16.7%, in each age group respectively (P<0.0001). Seroconversion occurred in 65.2% of individuals who were seronegative at inclusion compared to 6.8% in those who were initially seropositive.

CONCLUSIONS

Seroincidence of pH1N1/2009v infection was three times that estimated from clinical surveillance, indicating that almost two thirds of infections occurring at the community level have escaped medical detection. People under 20 years of age were the most affected group. Pre-epidemic titers ≥ 1/40 prevented seroconversion and are likely protective against infection. A concern was raised about the long term stability of the antibody responses.


DOI: 10.1371/journal.pone.0025738
PubMed: 21980532
PubMed Central: PMC3183080


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Pandemic influenza due to pH1N1/2009 virus: estimation of infection burden in Reunion Island through a prospective serosurvey, austral winter 2009.</title>
<author>
<name sortKey="Dellagi, Koussay" sort="Dellagi, Koussay" uniqKey="Dellagi K" first="Koussay" last="Dellagi">Koussay Dellagi</name>
<affiliation wicri:level="1">
<nlm:affiliation>GIS CRVOI, Centre de Recherche et de Veille sur les Maladies Emergentes dans l'Océan Indien, Saint-Denis, La Réunion. koussay.dellagi@ird.fr</nlm:affiliation>
<country wicri:rule="url">France</country>
</affiliation>
</author>
<author>
<name sortKey="Rollot, Olivier" sort="Rollot, Olivier" uniqKey="Rollot O" first="Olivier" last="Rollot">Olivier Rollot</name>
</author>
<author>
<name sortKey="Temmam, Sarah" sort="Temmam, Sarah" uniqKey="Temmam S" first="Sarah" last="Temmam">Sarah Temmam</name>
</author>
<author>
<name sortKey="Salez, Nicolas" sort="Salez, Nicolas" uniqKey="Salez N" first="Nicolas" last="Salez">Nicolas Salez</name>
</author>
<author>
<name sortKey="Guernier, Vanina" sort="Guernier, Vanina" uniqKey="Guernier V" first="Vanina" last="Guernier">Vanina Guernier</name>
</author>
<author>
<name sortKey="Pascalis, Herve" sort="Pascalis, Herve" uniqKey="Pascalis H" first="Hervé" last="Pascalis">Hervé Pascalis</name>
</author>
<author>
<name sortKey="Gerardin, Patrick" sort="Gerardin, Patrick" uniqKey="Gerardin P" first="Patrick" last="Gérardin">Patrick Gérardin</name>
</author>
<author>
<name sortKey="Fianu, Adrian" sort="Fianu, Adrian" uniqKey="Fianu A" first="Adrian" last="Fianu">Adrian Fianu</name>
</author>
<author>
<name sortKey="Lapidus, Nathanael" sort="Lapidus, Nathanael" uniqKey="Lapidus N" first="Nathanael" last="Lapidus">Nathanael Lapidus</name>
</author>
<author>
<name sortKey="Naty, Nadege" sort="Naty, Nadege" uniqKey="Naty N" first="Nadège" last="Naty">Nadège Naty</name>
</author>
<author>
<name sortKey="Tortosa, Pablo" sort="Tortosa, Pablo" uniqKey="Tortosa P" first="Pablo" last="Tortosa">Pablo Tortosa</name>
</author>
<author>
<name sortKey="Boussaid, Karim" sort="Boussaid, Karim" uniqKey="Boussaid K" first="Karim" last="Boussaïd">Karim Boussaïd</name>
</author>
<author>
<name sortKey="Jaffar Banjee, Marie Christine" sort="Jaffar Banjee, Marie Christine" uniqKey="Jaffar Banjee M" first="Marie-Christine" last="Jaffar-Banjee">Marie-Christine Jaffar-Banjee</name>
</author>
<author>
<name sortKey="Filleul, Laurent" sort="Filleul, Laurent" uniqKey="Filleul L" first="Laurent" last="Filleul">Laurent Filleul</name>
</author>
<author>
<name sortKey="Flahault, Antoine" sort="Flahault, Antoine" uniqKey="Flahault A" first="Antoine" last="Flahault">Antoine Flahault</name>
</author>
<author>
<name sortKey="Carrat, Fabrice" sort="Carrat, Fabrice" uniqKey="Carrat F" first="Fabrice" last="Carrat">Fabrice Carrat</name>
</author>
<author>
<name sortKey="Favier, Francois" sort="Favier, Francois" uniqKey="Favier F" first="Francois" last="Favier">Francois Favier</name>
</author>
<author>
<name sortKey="De Lamballerie, Xavier" sort="De Lamballerie, Xavier" uniqKey="De Lamballerie X" first="Xavier" last="De Lamballerie">Xavier De Lamballerie</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21980532</idno>
<idno type="pmid">21980532</idno>
<idno type="doi">10.1371/journal.pone.0025738</idno>
<idno type="pmc">PMC3183080</idno>
<idno type="wicri:Area/Main/Corpus">000349</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000349</idno>
<idno type="wicri:Area/Main/Curation">000349</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000349</idno>
<idno type="wicri:Area/Main/Exploration">000349</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Pandemic influenza due to pH1N1/2009 virus: estimation of infection burden in Reunion Island through a prospective serosurvey, austral winter 2009.</title>
<author>
<name sortKey="Dellagi, Koussay" sort="Dellagi, Koussay" uniqKey="Dellagi K" first="Koussay" last="Dellagi">Koussay Dellagi</name>
<affiliation wicri:level="1">
<nlm:affiliation>GIS CRVOI, Centre de Recherche et de Veille sur les Maladies Emergentes dans l'Océan Indien, Saint-Denis, La Réunion. koussay.dellagi@ird.fr</nlm:affiliation>
<country wicri:rule="url">France</country>
</affiliation>
</author>
<author>
<name sortKey="Rollot, Olivier" sort="Rollot, Olivier" uniqKey="Rollot O" first="Olivier" last="Rollot">Olivier Rollot</name>
</author>
<author>
<name sortKey="Temmam, Sarah" sort="Temmam, Sarah" uniqKey="Temmam S" first="Sarah" last="Temmam">Sarah Temmam</name>
</author>
<author>
<name sortKey="Salez, Nicolas" sort="Salez, Nicolas" uniqKey="Salez N" first="Nicolas" last="Salez">Nicolas Salez</name>
</author>
<author>
<name sortKey="Guernier, Vanina" sort="Guernier, Vanina" uniqKey="Guernier V" first="Vanina" last="Guernier">Vanina Guernier</name>
</author>
<author>
<name sortKey="Pascalis, Herve" sort="Pascalis, Herve" uniqKey="Pascalis H" first="Hervé" last="Pascalis">Hervé Pascalis</name>
</author>
<author>
<name sortKey="Gerardin, Patrick" sort="Gerardin, Patrick" uniqKey="Gerardin P" first="Patrick" last="Gérardin">Patrick Gérardin</name>
</author>
<author>
<name sortKey="Fianu, Adrian" sort="Fianu, Adrian" uniqKey="Fianu A" first="Adrian" last="Fianu">Adrian Fianu</name>
</author>
<author>
<name sortKey="Lapidus, Nathanael" sort="Lapidus, Nathanael" uniqKey="Lapidus N" first="Nathanael" last="Lapidus">Nathanael Lapidus</name>
</author>
<author>
<name sortKey="Naty, Nadege" sort="Naty, Nadege" uniqKey="Naty N" first="Nadège" last="Naty">Nadège Naty</name>
</author>
<author>
<name sortKey="Tortosa, Pablo" sort="Tortosa, Pablo" uniqKey="Tortosa P" first="Pablo" last="Tortosa">Pablo Tortosa</name>
</author>
<author>
<name sortKey="Boussaid, Karim" sort="Boussaid, Karim" uniqKey="Boussaid K" first="Karim" last="Boussaïd">Karim Boussaïd</name>
</author>
<author>
<name sortKey="Jaffar Banjee, Marie Christine" sort="Jaffar Banjee, Marie Christine" uniqKey="Jaffar Banjee M" first="Marie-Christine" last="Jaffar-Banjee">Marie-Christine Jaffar-Banjee</name>
</author>
<author>
<name sortKey="Filleul, Laurent" sort="Filleul, Laurent" uniqKey="Filleul L" first="Laurent" last="Filleul">Laurent Filleul</name>
</author>
<author>
<name sortKey="Flahault, Antoine" sort="Flahault, Antoine" uniqKey="Flahault A" first="Antoine" last="Flahault">Antoine Flahault</name>
</author>
<author>
<name sortKey="Carrat, Fabrice" sort="Carrat, Fabrice" uniqKey="Carrat F" first="Fabrice" last="Carrat">Fabrice Carrat</name>
</author>
<author>
<name sortKey="Favier, Francois" sort="Favier, Francois" uniqKey="Favier F" first="Francois" last="Favier">Francois Favier</name>
</author>
<author>
<name sortKey="De Lamballerie, Xavier" sort="De Lamballerie, Xavier" uniqKey="De Lamballerie X" first="Xavier" last="De Lamballerie">Xavier De Lamballerie</name>
</author>
</analytic>
<series>
<title level="j">PloS one</title>
<idno type="eISSN">1932-6203</idno>
<imprint>
<date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult (MeSH)</term>
<term>Cohort Studies (MeSH)</term>
<term>Female (MeSH)</term>
<term>France (epidemiology)</term>
<term>Humans (MeSH)</term>
<term>Influenza A Virus, H1N1 Subtype (genetics)</term>
<term>Influenza A Virus, H1N1 Subtype (immunology)</term>
<term>Influenza A Virus, H1N1 Subtype (pathogenicity)</term>
<term>Influenza, Human (blood)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (immunology)</term>
<term>Influenza, Human (virology)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Polymerase Chain Reaction (MeSH)</term>
<term>Prospective Studies (MeSH)</term>
<term>Seasons (MeSH)</term>
<term>Serologic Tests (MeSH)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>France (épidémiologie)</term>
<term>Grippe humaine (immunologie)</term>
<term>Grippe humaine (sang)</term>
<term>Grippe humaine (virologie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains (MeSH)</term>
<term>Jeune adulte (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Réaction de polymérisation en chaîne (MeSH)</term>
<term>Saisons (MeSH)</term>
<term>Sous-type H1N1 du virus de la grippe A (génétique)</term>
<term>Sous-type H1N1 du virus de la grippe A (immunologie)</term>
<term>Sous-type H1N1 du virus de la grippe A (pathogénicité)</term>
<term>Tests sérologiques (MeSH)</term>
<term>Études de cohortes (MeSH)</term>
<term>Études prospectives (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>France</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Influenza A Virus, H1N1 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Sous-type H1N1 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Grippe humaine</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en">
<term>Influenza A Virus, H1N1 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr">
<term>Sous-type H1N1 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr">
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>France</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Cohort Studies</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pandemics</term>
<term>Polymerase Chain Reaction</term>
<term>Prospective Studies</term>
<term>Seasons</term>
<term>Serologic Tests</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Pandémies</term>
<term>Réaction de polymérisation en chaîne</term>
<term>Saisons</term>
<term>Tests sérologiques</term>
<term>Études de cohortes</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>France</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>BACKGROUND</b>
</p>
<p>To date, there is little information that reflects the true extent of spread of the pH1N1/2009v influenza pandemic at the community level as infection often results in mild or no clinical symptoms. This study aimed at assessing through a prospective study, the attack rate of pH1N1/2009 virus in Reunion Island and risk factors of infection, during the 2009 season.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>METHODOLOGY/PRINCIPAL FINDINGS</b>
</p>
<p>A serosurvey was conducted during the 2009 austral winter, in the frame of a prospective population study. Pairs of sera were collected from 1687 individuals belonging to 772 households, during and after passage of the pandemic wave. Antibodies to pH1N1/2009v were titered using the hemagglutination inhibition assay (HIA) with titers ≥ 1/40 being considered positive. Seroprevalence during the first two weeks of detection of pH1N1/2009v in Reunion Island was 29.8% in people under 20 years of age, 35.6% in adults (20-59 years) and 73.3% in the elderly (≥ 60 years) (P<0.0001). Baseline corrected cumulative incidence rates, were 42.9%, 13.9% and 0% in these age groups respectively (P<0.0001). A significant decline in antibody titers occurred soon after the passage of the epidemic wave. Seroconversion rates to pH1N1/2009 correlated negatively with age: 63.2%, 39.4% and 16.7%, in each age group respectively (P<0.0001). Seroconversion occurred in 65.2% of individuals who were seronegative at inclusion compared to 6.8% in those who were initially seropositive.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>CONCLUSIONS</b>
</p>
<p>Seroincidence of pH1N1/2009v infection was three times that estimated from clinical surveillance, indicating that almost two thirds of infections occurring at the community level have escaped medical detection. People under 20 years of age were the most affected group. Pre-epidemic titers ≥ 1/40 prevented seroconversion and are likely protective against infection. A concern was raised about the long term stability of the antibody responses.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">21980532</PMID>
<DateCompleted>
<Year>2012</Year>
<Month>01</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>03</Month>
<Day>05</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1932-6203</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>6</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2011</Year>
</PubDate>
</JournalIssue>
<Title>PloS one</Title>
<ISOAbbreviation>PLoS ONE</ISOAbbreviation>
</Journal>
<ArticleTitle>Pandemic influenza due to pH1N1/2009 virus: estimation of infection burden in Reunion Island through a prospective serosurvey, austral winter 2009.</ArticleTitle>
<Pagination>
<MedlinePgn>e25738</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0025738</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To date, there is little information that reflects the true extent of spread of the pH1N1/2009v influenza pandemic at the community level as infection often results in mild or no clinical symptoms. This study aimed at assessing through a prospective study, the attack rate of pH1N1/2009 virus in Reunion Island and risk factors of infection, during the 2009 season.</AbstractText>
<AbstractText Label="METHODOLOGY/PRINCIPAL FINDINGS" NlmCategory="RESULTS">A serosurvey was conducted during the 2009 austral winter, in the frame of a prospective population study. Pairs of sera were collected from 1687 individuals belonging to 772 households, during and after passage of the pandemic wave. Antibodies to pH1N1/2009v were titered using the hemagglutination inhibition assay (HIA) with titers ≥ 1/40 being considered positive. Seroprevalence during the first two weeks of detection of pH1N1/2009v in Reunion Island was 29.8% in people under 20 years of age, 35.6% in adults (20-59 years) and 73.3% in the elderly (≥ 60 years) (P<0.0001). Baseline corrected cumulative incidence rates, were 42.9%, 13.9% and 0% in these age groups respectively (P<0.0001). A significant decline in antibody titers occurred soon after the passage of the epidemic wave. Seroconversion rates to pH1N1/2009 correlated negatively with age: 63.2%, 39.4% and 16.7%, in each age group respectively (P<0.0001). Seroconversion occurred in 65.2% of individuals who were seronegative at inclusion compared to 6.8% in those who were initially seropositive.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Seroincidence of pH1N1/2009v infection was three times that estimated from clinical surveillance, indicating that almost two thirds of infections occurring at the community level have escaped medical detection. People under 20 years of age were the most affected group. Pre-epidemic titers ≥ 1/40 prevented seroconversion and are likely protective against infection. A concern was raised about the long term stability of the antibody responses.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dellagi</LastName>
<ForeName>Koussay</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>GIS CRVOI, Centre de Recherche et de Veille sur les Maladies Emergentes dans l'Océan Indien, Saint-Denis, La Réunion. koussay.dellagi@ird.fr</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rollot</LastName>
<ForeName>Olivier</ForeName>
<Initials>O</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Temmam</LastName>
<ForeName>Sarah</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Salez</LastName>
<ForeName>Nicolas</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Guernier</LastName>
<ForeName>Vanina</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pascalis</LastName>
<ForeName>Hervé</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gérardin</LastName>
<ForeName>Patrick</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fianu</LastName>
<ForeName>Adrian</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lapidus</LastName>
<ForeName>Nathanael</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Naty</LastName>
<ForeName>Nadège</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tortosa</LastName>
<ForeName>Pablo</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Boussaïd</LastName>
<ForeName>Karim</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jaffar-Banjee</LastName>
<ForeName>Marie-Christine</ForeName>
<Initials>MC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Filleul</LastName>
<ForeName>Laurent</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Flahault</LastName>
<ForeName>Antoine</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Carrat</LastName>
<ForeName>Fabrice</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Favier</LastName>
<ForeName>Francois</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>de Lamballerie</LastName>
<ForeName>Xavier</ForeName>
<Initials>X</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2011</Year>
<Month>09</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>PLoS One</MedlineTA>
<NlmUniqueID>101285081</NlmUniqueID>
<ISSNLinking>1932-6203</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012621" MajorTopicYN="Y">Seasons</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012698" MajorTopicYN="N">Serologic Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2011</Year>
<Month>01</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2011</Year>
<Month>09</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2011</Year>
<Month>10</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2011</Year>
<Month>10</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2012</Year>
<Month>1</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">21980532</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pone.0025738</ArticleId>
<ArticleId IdType="pii">PONE-D-11-01569</ArticleId>
<ArticleId IdType="pmc">PMC3183080</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2011 Aug;17(8):1455-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21801623</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2010 Jun 10;362(23):2175-2184</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20558368</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2009 Nov 12;361(20):1945-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19745214</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Med. 2011 Jan 14;9:5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21235760</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Curr. 2010 Jan 19;2:RRN1145</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20126277</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Hyg (Lond). 1972 Dec;70(4):767-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">4509641</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2010 Feb 17;5(2):e9214</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20174643</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2010 May 19;5(5):e10722</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20502705</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2008 Jul 28;8:99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18662384</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Infect. 2012 Feb;18(2):177-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21635661</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2009 Jun 18;360(25):2605-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19423869</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2010 Mar 27;375(9720):1100-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20096450</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2010 Sep 07;5(9):e12562</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20830210</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2010 Aug 05;15(31):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20738992</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2010 Feb 04;15(5):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20144443</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2011 Mar 18;6(3):e17995</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21437256</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epidemiol Rev. 1996;18(1):64-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8877331</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2010 Apr 30;28(20):3558-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20307592</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2011 Feb 23;6(2):e17074</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21373639</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20365-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19918065</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2011 Feb 09;6(2):e16809</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21347418</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2010 Jun 28;5(6):e11341</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20596536</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2010 Oct 14;5(10):e13211</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20976224</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2010 Jul 14;5(7):e11601</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20644650</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Vaccine Immunol. 2010 Dec;17(12):1958-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20876823</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2011;6(6):e21340</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21701598</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Infect. 2011 May;17(5):732-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20731679</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2010 Jun 09;5(6):e11036</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20543954</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2011 Jan 31;6(1):e16496</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21304982</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2009 Oct 3;374(9696):1209-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19679345</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2011 Jan 15;203(2):158-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21288814</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Curr. 2009 Nov 16;1:RRN1130</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20029668</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 2011 Jun;49(6):2210-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21471339</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Viruses. 2010;2(4):782-795</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20648234</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2010 Apr 14;303(14):1383-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20388894</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2009 Jul 16;361(3):279-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19564632</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2011 Jan 18;6(1):e14555</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21267441</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Infect. 2010 Apr;16(4):309-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20121825</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Med J Aust. 2011 Jan 3;194(1):19-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21449863</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2011 Apr 21;6(4):e17919</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21533034</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2010 May 28;5(5):e10896</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20531946</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Chim Acta. 2005 Sep;359(1-2):1-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15936746</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Morb Mortal Wkly Rep. 2009 May 22;58(19):521-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19478718</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2011 Jan 31;6(1):e16650</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21304946</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2010 Oct 4;28(42):6852-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20723626</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>France</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Boussaid, Karim" sort="Boussaid, Karim" uniqKey="Boussaid K" first="Karim" last="Boussaïd">Karim Boussaïd</name>
<name sortKey="Carrat, Fabrice" sort="Carrat, Fabrice" uniqKey="Carrat F" first="Fabrice" last="Carrat">Fabrice Carrat</name>
<name sortKey="De Lamballerie, Xavier" sort="De Lamballerie, Xavier" uniqKey="De Lamballerie X" first="Xavier" last="De Lamballerie">Xavier De Lamballerie</name>
<name sortKey="Favier, Francois" sort="Favier, Francois" uniqKey="Favier F" first="Francois" last="Favier">Francois Favier</name>
<name sortKey="Fianu, Adrian" sort="Fianu, Adrian" uniqKey="Fianu A" first="Adrian" last="Fianu">Adrian Fianu</name>
<name sortKey="Filleul, Laurent" sort="Filleul, Laurent" uniqKey="Filleul L" first="Laurent" last="Filleul">Laurent Filleul</name>
<name sortKey="Flahault, Antoine" sort="Flahault, Antoine" uniqKey="Flahault A" first="Antoine" last="Flahault">Antoine Flahault</name>
<name sortKey="Gerardin, Patrick" sort="Gerardin, Patrick" uniqKey="Gerardin P" first="Patrick" last="Gérardin">Patrick Gérardin</name>
<name sortKey="Guernier, Vanina" sort="Guernier, Vanina" uniqKey="Guernier V" first="Vanina" last="Guernier">Vanina Guernier</name>
<name sortKey="Jaffar Banjee, Marie Christine" sort="Jaffar Banjee, Marie Christine" uniqKey="Jaffar Banjee M" first="Marie-Christine" last="Jaffar-Banjee">Marie-Christine Jaffar-Banjee</name>
<name sortKey="Lapidus, Nathanael" sort="Lapidus, Nathanael" uniqKey="Lapidus N" first="Nathanael" last="Lapidus">Nathanael Lapidus</name>
<name sortKey="Naty, Nadege" sort="Naty, Nadege" uniqKey="Naty N" first="Nadège" last="Naty">Nadège Naty</name>
<name sortKey="Pascalis, Herve" sort="Pascalis, Herve" uniqKey="Pascalis H" first="Hervé" last="Pascalis">Hervé Pascalis</name>
<name sortKey="Rollot, Olivier" sort="Rollot, Olivier" uniqKey="Rollot O" first="Olivier" last="Rollot">Olivier Rollot</name>
<name sortKey="Salez, Nicolas" sort="Salez, Nicolas" uniqKey="Salez N" first="Nicolas" last="Salez">Nicolas Salez</name>
<name sortKey="Temmam, Sarah" sort="Temmam, Sarah" uniqKey="Temmam S" first="Sarah" last="Temmam">Sarah Temmam</name>
<name sortKey="Tortosa, Pablo" sort="Tortosa, Pablo" uniqKey="Tortosa P" first="Pablo" last="Tortosa">Pablo Tortosa</name>
</noCountry>
<country name="France">
<noRegion>
<name sortKey="Dellagi, Koussay" sort="Dellagi, Koussay" uniqKey="Dellagi K" first="Koussay" last="Dellagi">Koussay Dellagi</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000369 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000369 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:21980532
   |texte=   Pandemic influenza due to pH1N1/2009 virus: estimation of infection burden in Reunion Island through a prospective serosurvey, austral winter 2009.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:21980532" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeFranceV1 

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Sun Aug 9 07:31:43 2020. Site generation: Thu Mar 25 22:05:26 2021